Real-world evaluation of the feasibility and quality of PCI guidance using Dynamic Coronary Roadmap: A secondary analysis of the DCR4Contrast Multicenter, International Randomized Control Trial.
John C. Messenger, M.D., MSCAI, University of Colorado Anschutz Medical Campus, Denver, CO, Aaron Louis Strobel, M.D., FSCAI, Arkansas Cardiology, Little Rock, AR, Haim Danenberg, MD, Hadassah University Medical Center, Hadassah, Israel, Israel, Frederic De Vroey, MD, Grand Hopital de Charleroi, Charleroi, Charleroi, Belgium, Ajay J. Kirtane, M.D., FSCAI, NewYork-Presbyterian Columbia University Irving Medical Center, New York, NY, Manish A. Parikh, M.D., FSCAI, New York-Presbyterian, New York, NY, Dimitrios Karmpaliotis, M.D., FSCAI, Atlantic Health Morristown Medical Center, Morristown, NJ, Breda Hennessey, MD, Hospital Clinico San Carlos, Madrid, Madrid, Spain, Alejandro Curcio, MD, Hospital Universitario de Fuenlabrada, Madrid, Fuenlabrada, Spain, Martijn van Mourik, MSc, PhD, Philips, Cambridge, MA, Peter Eshuis, MSc, PhD, Philips Healthcare, Cambridge, MA and Javier Escaned, M.D., Ph.D., Hospital Clínico San Carlos, Madrid, Spain